Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Daniela R. Nebuloni"'
Autor:
Luciana Kikuchi, Alice M. Isejima, Paulo M. Hoff, Marcelo Queiroz, Leonardo Gomes da Fonseca, Maria Ignez Braghiroli, Joao Glasberg, Christian Kappeler, Luiz Antonio Senna Leite, Daniela R. Nebuloni, Giovanni M. Bariani, Rachel P. Riechelmann, Thomas Giollo Rivelli
Publikováno v:
The Oncologist. 24:1180-1187
Background Regorafenib is a multikinase inhibitor with antiangiogenic effects that improves overall survival (OS) in metastatic colorectal cancer (mCRC) after failure of standard therapies. We investigated the efficacy and safety of regorafenib in an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::812ae0feedab605e749745e5d491aa9d
https://doi.org/10.1634/theoncologist.2019-0067
https://doi.org/10.1634/theoncologist.2019-0067
Autor:
G. C. Cotti, O.F.M. Braghiroli, A. Alex, Cintia Ortega, Camila Motta Venchiarutti Moniz, Jorge Sabbaga, Abraão Dornellas, T. Giollo Rivelli, S.C. Nahas, Paulo M. Hoff, F. Caparelli, R. Riechelmann, L.A. Senna Leite, Maria Ignez Braghiroli, L. Alban, K. Moutinho, Caio Sergio Rizkallah Nahas, Giovanni M. Bariani, Daniela R. Nebuloni, I. Ceconello
Publikováno v:
Annals of Oncology. 31:S416
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::679dceb341c1cd37c7b3afa1c92b877d
https://doi.org/10.1016/j.annonc.2020.08.522
https://doi.org/10.1016/j.annonc.2020.08.522
Autor:
Rachel P. Riechelmann, Paulo Schiavom Duarte, Jose Mauricio Mota, Giovanni M. Bariani, Paulo M. Hoff, Maria Ignez Braghiroli, Daniela R. Nebuloni, Carlos Alberto Buchpiguel, Tiago O Morita
Publikováno v:
Nuclear medicine communications. 39(3)
Background Advanced biliary tract cancers have a dismal prognosis. Treatment with gemcitabine plus cisplatin has resulted in a significant improvement in survival; however, early assessment of outcomes poses a challenge. Objective We carried out a pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34ea6275c62da651332a282fabc26c92
https://pubmed.ncbi.nlm.nih.gov/29381586
https://pubmed.ncbi.nlm.nih.gov/29381586
Autor:
Luiz Senna, Irina Raicher, PreOx Workgroup, Julia Tizue Fukushima, Carlos Otto Heise, Ricardo Galhardoni, Ricardo Silvestre e Silva Macarenco, William Gemio Jacobsen Teixeira, Paulo M. Hoff, Daniella C Parravano, K.A.S.L. Ferreira, Helena Brentani, Rosana L. Pagano, Daniela R. Nebuloni, Rachel P. Riechelmann, Alberto Andrade de Mello, Ângela M de Souza, Didier Bouhassira, Camila Squarzoni Dale, Rubens Gisbert Cury, Marcelo Zini Megale, Alexandra Paola Zandonai, Manoel Jacobsen Teixeira, Evandro Sobroza, Luciana Mendes Bahia, Jean-Pascal Lefaucheur, Nathalia Scisci, Thais Chile, Luiz Henrique Dourado, Valquíria Aparecida da Silva, Daniel Ciampi de Andrade, Mario Wilson Iervolino Brotto, Antonia Lilian de Lima Rodrigues, Fernanda Valério da Silva, Daniel Fernandes Saragiotto, Paula Braz Mileno
Publikováno v:
The Oncologist
Lessons Learned Pregabalin is a medication that can decrease neuronal hyperexcitability, relieve neuropathic pain, and reach stable plasma levels after a titration period of only a few days. Its use during oxaliplatin infusions was not able to decrea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e05abbcec0227789b7164861fe300af8
https://pubmed.ncbi.nlm.nih.gov/28652279
https://pubmed.ncbi.nlm.nih.gov/28652279
Autor:
Giovanni M. Bariani, Daniela R. Nebuloni, Lucila Soares da Silva Rocha, Fernanda Capareli, Rachel P. Riechelmann, Luiz Antonio Senna Leite, Rodrigo Nogueira Fogace, Paulo M. G. Hoff, Thomas Giollo Rivelli
Publikováno v:
Brazilian Journal of Oncology. 13
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ceacfa573478ffb99f83285eac6416d2
https://doi.org/10.26790/bjo20171346a177
https://doi.org/10.26790/bjo20171346a177
Autor:
Jorge Sabbaga, Daniel Fernandes Saragiotto, Fabiano Hahn Souza, Paulo M. Hoff, Daniela R. Nebuloni, Milena Perez Mak, Gilberto de Castro, Thiago Júlio
Publikováno v:
Molecular and Clinical Oncology. 1:175-179
Incorporation of new drugs for treatment of metastatic colorectal cancer (mCRC) has led to a clear improvement in overall patient survival, the added cost of treatment, however, is a major concern worldwide. The cost-effectiveness of using a modified
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25e80e0a6c8e5b2a6ec6a4ff75d6e1d9
https://doi.org/10.3892/mco.2012.12
https://doi.org/10.3892/mco.2012.12
Autor:
Thomas Giollo Rivelli, Giovanni M. Bariani, Christian Kappeler, Luiz Antonio Senna Leite, Paulo M. Hoff, Daniela R. Nebuloni, Marcelo Queiroz, Kaline M. C. Pereira, Rachel P. Riechelmann, Joao Glasberg, Fabiola Puty
Publikováno v:
Journal of Clinical Oncology. 36:782-782
782 Background: The oral multikinase inhibitor regorafenib improves overall survival in advanced colorectal cancer (CRC). The aim of this study was to investigate the safety and efficacy of regorafenib in antiangiogenic-naïve patients with chemother
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5b7cf19d7b9b0ed77ee24824feb013b7
https://doi.org/10.1200/jco.2018.36.4_suppl.782
https://doi.org/10.1200/jco.2018.36.4_suppl.782
Autor:
Maria Ignez Braghiroli, Luiz Senna, A. Alex, Anezka C R de Celis Ferrari, Rachel P. Riechelmann, Allyne S Carneiro, Paulo M. Hoff, Daniela R. Nebuloni, Juliana Lobo, Fernanda Caparelli, Tulio Edouardo Pfiffer
Publikováno v:
ecancermedicalscience
Background In patients with adenocarcinoma of the pancreas, there are no standard second-line regimens. Many pre-clinical studies have shown that metformin alone or when combined with paclitaxel has antitumour effects on this tumour. We have tested h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d656324d95e4c3a9156676cad0276fb
https://pubmed.ncbi.nlm.nih.gov/26316884
https://pubmed.ncbi.nlm.nih.gov/26316884
Autor:
Giovanni M. Bariani, Rachel P. Riechelmann, Alexandra Khichfy Alex, Daniela R. Nebuloni, Caio Sergio Rizkallah Nahas, Maria Ignez Braghiroli, Joao Glasberg, Suilane Coelho Ribeiro, Camila Motta Venchiarutti Moniz, Renata A. Coudry, Allyne Q. Carneiro, Paulo M. Hoff
Publikováno v:
Journal of Clinical Oncology. 32:560-560
659 Background: Squamous cell carcinoma (SCC) of the anal canal is an uncommon malignancy accounting for 1-5% of intestinal tumors; however, its incidence has been increasing. The standard treatment of anal canal SCC stage II-III consists of infusion
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e2860e8d1814b45600e88540f74a4ea
https://doi.org/10.1200/jco.2014.32.3_suppl.560
https://doi.org/10.1200/jco.2014.32.3_suppl.560
Autor:
Milena Perez Mak, J. Sabbaga, F.H. Souza, Gilberto de Castro, Paulo M. Hoff, Daniel Fernandes Saragiotto, Daniela R. Nebuloni
Publikováno v:
European Journal of Cancer. 47:S262
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b73d9a88c373a5d2c600e3b42259d225
https://doi.org/10.1016/s0959-8049(11)71209-6
https://doi.org/10.1016/s0959-8049(11)71209-6